Skip to main content

Market Overview

Morning Market Losers

Share:

Apollo Education Group, Inc. ( (NASDAQ: APOL) shares dipped 13.94% to $27.42 after the company posted downbeat quarterly revenue and lowered its 2015 outlook. However, the company reported better-than-expected earnings for the first quarter.

Broadwind Energy, Inc. ( (NASDAQ: BWEN) fell 11.74% to $4.96 after the company lowered its Q4 outlook.

Insulet Corporation(NASDAQ: PODD) shares slipped 10.03% to $40.06 after the company lowered its FY2014 sales guidance.

Stemline Therapeutics, Inc. ( (NASDAQ: STML) shares dropped 8.74% to $15.97 after the company priced $59.85 million public offering of common stock.

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) shares dipped 7.10% to $15.17. Infinity Pharmaceuticals' Phase 2 study Of Duvelisib with background methotrexate in patients with moderate-to-severe rheumatoid arthritis did not meet primary endpoint.

AmTrust Financial Services, Inc. (NASDAQ: AFSI) shares declined 4.88% to $51.37 after the company announced the pricing of a three million share offering.

WD-40 Company (NASDAQ: WDFC) shares fell 3.86% to $82.18 after the company reported weaker-than-expected first quarter results.

GW Pharmaceuticals PLC- ADR(NASDAQ: GWPH) dropped 2.99% to $68.93 following disappointing results from its Sativex drug trial.

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares fell 1.08% to $185.90 after the company provided update on Phase 2 clinical trial with Eculizumab.

 

Related Articles (APOL + BWEN)

View Comments and Join the Discussion!

Posted-In: market losersNews Movers & Shakers Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com